vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and PRA GROUP INC (PRAA). Click either name above to swap in a different company.
PRA GROUP INC is the larger business by last-quarter revenue ($333.4M vs $270.8M, roughly 1.2× HUTCHMED (China) Ltd). PRA GROUP INC runs the higher net margin — 17.0% vs 0.7%, a 16.2% gap on every dollar of revenue. On growth, PRA GROUP INC posted the faster year-over-year revenue change (13.7% vs -16.5%). HUTCHMED (China) Ltd produced more free cash flow last quarter ($3.4M vs $-90.4M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
PRA Group, Inc. is a publicly traded debt buyer and debt collection company based in Norfolk, Virginia. The company buys delinquent consumer debt from credit card issuers and other financial institutions at a discount and pursues collection of the full debt owed. Founded in 1996, PRA Group employs more than 3200 people in 18 countries.
HCM vs PRAA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $333.4M |
| Net Profit | $2.0M | $56.5M |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | 37.7% |
| Net Margin | 0.7% | 17.0% |
| Revenue YoY | -16.5% | 13.7% |
| Net Profit YoY | -83.6% | 206.3% |
| EPS (diluted) | $0.00 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $333.4M | ||
| Q3 25 | — | $311.1M | ||
| Q2 25 | $277.7M | $287.7M | ||
| Q1 25 | $324.5M | $269.6M | ||
| Q4 24 | — | $293.2M | ||
| Q3 24 | — | $281.5M | ||
| Q2 24 | $305.7M | $284.2M | ||
| Q1 24 | — | $255.6M |
| Q4 25 | $2.0M | $56.5M | ||
| Q3 25 | — | $-407.7M | ||
| Q2 25 | $455.0M | $42.4M | ||
| Q1 25 | $11.9M | $3.7M | ||
| Q4 24 | — | $18.5M | ||
| Q3 24 | — | $27.2M | ||
| Q2 24 | $25.8M | $21.5M | ||
| Q1 24 | — | $3.5M |
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | -13.2% | 37.7% | ||
| Q3 25 | — | -101.4% | ||
| Q2 25 | -1.3% | 29.6% | ||
| Q1 25 | -5.0% | 27.7% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | — | 32.0% | ||
| Q2 24 | -9.0% | 31.4% | ||
| Q1 24 | — | 26.0% |
| Q4 25 | 0.7% | 17.0% | ||
| Q3 25 | — | -131.0% | ||
| Q2 25 | 163.8% | 14.7% | ||
| Q1 25 | 3.7% | 1.4% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | — | 9.6% | ||
| Q2 24 | 8.4% | 7.6% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | $0.00 | $1.47 | ||
| Q3 25 | — | $-10.43 | ||
| Q2 25 | $0.52 | $1.08 | ||
| Q1 25 | $0.01 | $0.09 | ||
| Q4 24 | — | $0.47 | ||
| Q3 24 | — | $0.69 | ||
| Q2 24 | $0.03 | $0.54 | ||
| Q1 24 | — | $0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $104.4M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $979.9M |
| Total Assets | $1.8B | $5.1B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $104.4M | ||
| Q3 25 | — | $107.5M | ||
| Q2 25 | $1.4B | $131.6M | ||
| Q1 25 | $836.1M | $128.7M | ||
| Q4 24 | — | $105.9M | ||
| Q3 24 | — | $141.1M | ||
| Q2 24 | $802.5M | $118.9M | ||
| Q1 24 | — | $108.1M |
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $979.9M | ||
| Q3 25 | — | $928.5M | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $759.9M | $1.2B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | $740.1M | $1.1B | ||
| Q1 24 | — | $1.1B |
| Q4 25 | $1.8B | $5.1B | ||
| Q3 25 | — | $5.0B | ||
| Q2 25 | $1.8B | $5.4B | ||
| Q1 25 | $1.3B | $5.1B | ||
| Q4 24 | — | $4.9B | ||
| Q3 24 | — | $4.9B | ||
| Q2 24 | $1.3B | $4.7B | ||
| Q1 24 | — | $4.5B |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $-85.5M |
| Free Cash FlowOCF − Capex | $3.4M | $-90.4M |
| FCF MarginFCF / Revenue | 1.2% | -27.1% |
| Capex IntensityCapex / Revenue | 1.8% | 1.4% |
| Cash ConversionOCF / Net Profit | 4.21× | -1.51× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $-169.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $-85.5M | ||
| Q3 25 | — | $-10.1M | ||
| Q2 25 | $-72.9M | $-12.9M | ||
| Q1 25 | $40.3M | $-52.6M | ||
| Q4 24 | — | $-94.6M | ||
| Q3 24 | — | $-35.0M | ||
| Q2 24 | $-39.8M | $-29.5M | ||
| Q1 24 | — | $-73.0M |
| Q4 25 | $3.4M | $-90.4M | ||
| Q3 25 | — | $-11.3M | ||
| Q2 25 | $-82.2M | $-14.2M | ||
| Q1 25 | $32.5M | $-53.5M | ||
| Q4 24 | — | $-98.6M | ||
| Q3 24 | — | $-36.1M | ||
| Q2 24 | $-49.9M | $-30.8M | ||
| Q1 24 | — | $-73.5M |
| Q4 25 | 1.2% | -27.1% | ||
| Q3 25 | — | -3.6% | ||
| Q2 25 | -29.6% | -4.9% | ||
| Q1 25 | 10.0% | -19.8% | ||
| Q4 24 | — | -33.6% | ||
| Q3 24 | — | -12.8% | ||
| Q2 24 | -16.3% | -10.8% | ||
| Q1 24 | — | -28.8% |
| Q4 25 | 1.8% | 1.4% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | 3.3% | 0.4% | ||
| Q1 25 | 2.4% | 0.3% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | 3.3% | 0.5% | ||
| Q1 24 | — | 0.2% |
| Q4 25 | 4.21× | -1.51× | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.16× | -0.30× | ||
| Q1 25 | 3.38× | -14.37× | ||
| Q4 24 | — | -5.13× | ||
| Q3 24 | — | -1.29× | ||
| Q2 24 | -1.54× | -1.37× | ||
| Q1 24 | — | -21.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
PRAA
| GB | $170.1M | 51% |
| Other | $163.3M | 49% |
